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Previews
were expressed at low level relative to that observedPriming the Hematopoietic Pump
in committed precursors. Moreover, it was argued that
lineage promiscuity (based on marker expression) does
not alter the lineage potential of the progenitors them-
selves. Given that only a fraction, albeit a substantialMarkers of multiple hematopoietic lineages are ex-
fraction (perhaps 60%), of prospectively purified pro-pressed in multipotent progenitors, a phenomenon re-
genitors generate colonies in vitro, one might still debateferred to as “lineage priming.” A new study in this
the validity of these conclusions.issue of Immunity provides compelling evidence that
Here is where the findings of Ye and colleagues pro-such “promiscuous” gene expression occurs in hema-
vide new and more compelling evidence in behalf of thetopoietic stem cells and does not interfere with their
lineage priming model (Ye et al., 2003). In their elegantlong-term repopulation potential.
experiments they employed a Cre-LoxP approach to
fate mapping of cells expressing the myeloid cell markerHematopoiesis serves as a valuable paradigm for how
lysozyme. By interbreeding two mouse stains—onemultipotential stem cells ultimately generate precursor
bearing a reporter lysozyme locus into which yellowcells committed to single lineages (Orkin, 2000). In prin-
fluorescent protein sequences (EYFP) were insertedciple, nature has two quite different strategies from
such that expression only occurs following Cre-medi-which to choose. On the one hand, hematopoietic stem
ated excision of a stopper cassette and a second har-cells (HSCs) might be viewed as a blank slate such that
boring a lysozyme Cre-knockin allele—the ancestry ofactivation of lineage-specific programs, either intrinsi-
cells could be traced. The key finding is that EYFP ex-cally or by extrinsic influences, would be synonymous
pression was observed not only in myeloid cells butwith lineage commitment. Accordingly, a simple one-
also in lymphoid cells and even a proportion of HSCs.to-one correspondence of lineage-specific markers and
Transplantation of EYFP HSCs into recipient mice ledlineage selection would be evident. Alternatively, HSCs
to hematopoietic reconstitution in which all hematopoi-might have a wider array of lineage programs repre-
etic cells were EYFP. Thus, HSCs that expressed lyso-sented, perhaps at low level or in partial form, thereby
zyme at some point in their existence are not impaired
allowing for rapid fixation of lineage following subse-
with respect to long-term hematopoietic potential. Ap-
quent internal or external cues. Examining lineage-spe-
propriate controls and caveats are described to make
cific markers in progenitors whose fate is not yet sealed
this conclusion persuasive.
would present a fluid and heterogeneous snapshot of
If we accept the notion that lineage-restricted genes,
blood cell development.
including many of the essential nuclear regulatory fac-
Findings of the past decade have lent support to the tors, are in an activated configuration in HSCs and
latter possibility. Often referred to as “lineage priming,” multipotent progenitors, we must face the inevitable
this hypothesis proposes that genes representative of question: what constitutes lineage commitment? The
multiple lineages are promiscuously expressed preced- concept of commitment is further challenged by evi-
ing commitment to a single lineage (Hu et al., 1997). dence that hematopoietic lineages are less stable than
Whether this is a “warm up” for full lineage differentiation previously considered. Changes in single regulatory fac-
or merely a reflection of leakiness of regulatory mecha- tors may decommit a committed precursor to a more
nisms operative in immature progenitors or HSCs is un- immature state or recommit a committed progenitor to
certain. Studies by Enver, Greaves, and their colleagues another fate (Heavey et al., 2003; Querfurth et al., 2000).
described DNase I sensitivity of the -globin locus con- Commitment is a relative term in which the options avail-
trol region, a measure of its activation, in multipotential able to a cell must be viewed in the context of its current
myeloid cells of the FDCP-mix line (Jimenez et al., 1992). state and milieu. Commitment reflects a constant battle
They also reported coexpression of lineage markers, between opposing forces, each hoping to win the favor
such as myeloperoxidase (MPO) and-globin, in individ- of the progenitor cell (Orkin, 2000). Only when the regula-
ual FDCP-mix cells, as determined by single-cell RT- tory pathways promoting alternative lineages are si-
PCR (Hu et al., 1997). Corroborating analyses were also lenced and permanently maintained in that state is com-
performed with human linCD34 cells and progenitors mitment a done deal.
derived from the mouse aorta-gonad-mesonephros re- The problem of developmental potential can now be
gion (Delassus et al., 1999). While provocative, the re- reframed into a consideration of how multipotentiality
sults of these studies are not entirely compelling to some is encoded in HSCs or more generally in other stem cell
as they might pertain only to cultured cells or impure types. Although more work is needed, it would appear
cell populations. More recent findings of Miyamoto et that genes reflective of diverse hematopoietic lineages
al. in prospectively purified hematopoietic progenitors are poised for expression in HSCs. Notably, genes repre-
argue against this interpretation (Miyamoto et al., 2002). sentative of nonhematopoietic lineages are not found
Indeed, common myeloid progenitors (CMPs) expressed in an open chromatin context. Hence, mechanisms exist
genes reflective of several myeloid, but not lymphoid, to distinguish hematopoietic from nonhematopoietic ex-
lineages. Conversely, common lymphoid progenitors pressed loci and prepare their chromatin domains for
(CLPs) expressed markers of T and B cell differentiation, active expression thereafter. Though gene activation un-
doubtedly must take place during hematopoietic lineagebut not myeloid markers. In both instances, markers
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choice, active repression of critical targets and path- Howard Hughes Medical Institute
Boston, Massachusetts 02115ways plays a crucial, and perhaps pivotal, role in final
commitment. The extent to which this holds for other
tissue-restricted stem cells or for embryonic stem cells
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via ARF6-mediated trafficking to the plasma membraneAmplifying Btk’s Signal
(Honda et al., 1999), relatively little is known about PIP5K
activation in lymphocytes. New data from Carpenter and
colleagues suggest that the Tec kinase Btk is a key
player in this process (Figure 1) (Saito et al., 2003).
The Tec family of nonreceptor tyrosine kinases are
The Tec kinase Btk is an important regulator of antigen notable for their amino-terminal pleckstrin homology do-
receptor activation of phospholipase C- (PLC-). mains, which bind to the products of PI3K, and PI3K
Data from Carpenter and colleagues (Saito et al., 2003, activity is required for their function (reviewed in Schaef-
this issue of Immunity) now suggest that Btk also fer and Schwartzberg, 2000). Mutations affecting Btk
activates phosphatidylinositol-4-phosphate 5-kinase
cause the human immunodeficiency X-linked agamma-
(PIP5K), thereby stimulating a positive feedback loop
globulinemia (XLA) and the mouse mutant X-linked im-
that generates PI(4,5)P2, the substrate for both phos- munodeficiency, which are associated with impaired
phoinositide 3-kinase (PI3K) and PLC-.
responses to B cell receptor engagement. Studies of Btk-
deficient cells revealed that Btk is an important regulator
of antigen-receptor-induced Ca2 mobilization (Fluck-Phosphoinositides are critical intermediates that regu-
iger et al., 1998; Takata and Kurosaki, 1996). Cells lack-late many cellular processes including cell survival,
ing Btk show defects in sustained Ca2 influx, which aregrowth and proliferation, Ca2 mobilization, membrane
associated with decreased phosphorylation of PLC-trafficking, cytoskeletal rorganization, and migration
and impaired IP3 production. Tec kinases have also been(Takenawa and Itoh, 2001). PI3K, which generates phos-
implicated in similar roles downstream of the Fc recep-phatidylinositol-3,4,5-trisphosphate (PIP3), a phospho-
tor in mast cells and the T cell receptor in T lymphocytes.inositide that binds to and activates proteins containing
As a consequence, lymphocytes deficient in Tec kinasespleckstrin homology domains, is an important compo-
show decreased activation of multiple downstream read-nent of immunoreceptor signaling. Similarly, PLC-,
outs dependent on IP3 and DAG production, includingwhich generates inositol trisphosphate (IP3) and diacyl-
activation of transcription factors, MAP kinases, andglycerol (DAG), is a key activator of Ca2 mobilization
protein kinase C (Schaeffer and Schwartzberg, 2000).and PKC/Ras-mediated pathways. Both PI3K and PLC-
Although Btk has been implicated in the direct phos-share the common substrate, phosphoinositide 4,5 bis-
phorylation of PLC-, tyrosine phosphorylation of PLC-phosphate [PI(4,5)P2], the product of phosphatidylinosi-
can still be observed in lymphocytes deficient in Tectol-4-phosphate 5-kinase (PIP5K). PI(4,5)P2 is one of the
kinases, despite clear Ca2 defects (Fluckiger et al.,most highly abundant phosphoinositides, yet, in other
1998; Schaeffer and Schwartzberg, 2000). Thus, it re-systems, receptor activation can significantly decrease
mained unclear whether phosphorylation was the onlyPI(4,5)P2 levels. Replenishing PI(4,5)P2 levels should
mechanism by which Tec kinases regulate PLC- activ-therefore be important for sustaining receptor responses.
Although Rac has been implicated in activation of PIP5K ity. Moreover, overexpression of either wild-type or ki-
